DE69738503D1 - Den nachweis von oxidierten und mda-modifizierten lipoproteinen geringer dichte - Google Patents

Den nachweis von oxidierten und mda-modifizierten lipoproteinen geringer dichte

Info

Publication number
DE69738503D1
DE69738503D1 DE69738503T DE69738503T DE69738503D1 DE 69738503 D1 DE69738503 D1 DE 69738503D1 DE 69738503 T DE69738503 T DE 69738503T DE 69738503 T DE69738503 T DE 69738503T DE 69738503 D1 DE69738503 D1 DE 69738503D1
Authority
DE
Germany
Prior art keywords
mda
oxidized
detection
less density
modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69738503T
Other languages
English (en)
Other versions
DE69738503T2 (de
Inventor
Paul Noel Holvoet
Desire Jose Collen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Katholieke Universiteit Leuven
Original Assignee
Katholieke Universiteit Leuven
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Katholieke Universiteit Leuven filed Critical Katholieke Universiteit Leuven
Publication of DE69738503D1 publication Critical patent/DE69738503D1/de
Application granted granted Critical
Publication of DE69738503T2 publication Critical patent/DE69738503T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE69738503T 1997-06-20 1997-07-01 Versuchsanordnungen, antikörper und standards für den nachweis von oxidierten und mda-modifizierten lipoproteinen geringer dichte Expired - Lifetime DE69738503T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP9703287 1997-06-20
WOPCT/EP97/03287 1997-06-20
PCT/EP1997/003493 WO1998059248A1 (en) 1997-06-20 1997-07-01 Assays, antibodies, and standards for detection of oxidized and mda-modified low density lipoproteins

Publications (2)

Publication Number Publication Date
DE69738503D1 true DE69738503D1 (de) 2008-03-20
DE69738503T2 DE69738503T2 (de) 2009-02-26

Family

ID=8166668

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69738503T Expired - Lifetime DE69738503T2 (de) 1997-06-20 1997-07-01 Versuchsanordnungen, antikörper und standards für den nachweis von oxidierten und mda-modifizierten lipoproteinen geringer dichte

Country Status (9)

Country Link
EP (1) EP1021728B8 (de)
JP (1) JP4233120B2 (de)
AT (1) ATE385575T1 (de)
AU (1) AU3442397A (de)
CA (1) CA2294355C (de)
DE (1) DE69738503T2 (de)
ES (1) ES2299186T3 (de)
NZ (1) NZ502369A (de)
WO (1) WO1998059248A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6727102B1 (en) 1997-06-20 2004-04-27 Leuven Research & Development Vzw Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins
US6309888B1 (en) * 1998-09-04 2001-10-30 Leuven Research & Development Vzw Detection and determination of the stages of coronary artery disease
US6596544B1 (en) 2000-03-31 2003-07-22 The Regents Of The University Of California Functional assay of high-density lipoprotein
US7250304B2 (en) 2000-03-31 2007-07-31 The Regents Of The University Of California Functional assay of high-density lipoprotein
DK1272666T3 (da) * 2000-03-31 2006-02-27 Univ California Et funktionsassay for höjdensitetslipoprotein
WO2001088547A2 (en) * 2000-05-12 2001-11-22 The Regents Of The University Of California Standardized oxidized ldl assay
GB0017641D0 (en) * 2000-07-18 2000-09-06 Medigene Oy Peptides and their use
PT1328289E (pt) 2000-10-20 2008-12-10 Hamburger Stiftung Zur Foerder Proteínas oxidadas e sua actividade biológica e terapêutica, assim como sua utilização em diagnóstico através da inibição da interacção entre as proteínas oxidadas e cd36
JP4781169B2 (ja) * 2006-05-31 2011-09-28 積水メディカル株式会社 再狭窄の発症リスクを判定する方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3115587B2 (ja) * 1990-11-07 2000-12-11 第一化学薬品株式会社 モノクローナル抗体及びマロンジアルデヒド化低比重リポタンパクの測定法
WO1994023302A1 (en) * 1993-04-07 1994-10-13 The Australian National University Immunological assay of oxidatively modified human low density lipoproteins in plasma

Also Published As

Publication number Publication date
ATE385575T1 (de) 2008-02-15
AU3442397A (en) 1999-01-04
CA2294355A1 (en) 1998-12-30
EP1021728B8 (de) 2008-04-23
WO1998059248A1 (en) 1998-12-30
ES2299186T3 (es) 2008-05-16
JP2002512695A (ja) 2002-04-23
NZ502369A (en) 2001-11-30
DE69738503T2 (de) 2009-02-26
EP1021728A1 (de) 2000-07-26
CA2294355C (en) 2006-11-28
JP4233120B2 (ja) 2009-03-04
EP1021728B1 (de) 2008-02-06

Similar Documents

Publication Publication Date Title
DE69833118D1 (de) Immunoassay zum bestimmen von bnp
WO2000007025A3 (en) Methods for predicting drug response, in particular igf-i
DK0807691T3 (da) Fremgangsmåde til screening for tilstedeværelse af en genetisk defekt forbundet med trombose og/eller lav antikoagulant reaktion på aktiveret protein C
DE69320273D1 (de) Probenanalyse durch kapillarelektrophoretische Immunosubtraktion
DK0720746T3 (da) Fremgangsmåde, reagens og sæt til detektering af fækalt okkult blod
WO2003061569A3 (en) High-density lipoprotein assay device and method
DE69333569D1 (de) Magnetisch assistierte bindungsassays unter verwendung von magnetisch markierten bindungspartnern.
DE19781837T1 (de) Automatischer Immunoassay-Analysator
DE69738503D1 (de) Den nachweis von oxidierten und mda-modifizierten lipoproteinen geringer dichte
DE3670294D1 (de) Monoklonale antikoerper gegen kernproteine von lymphadenopathie-assoziierten viren.
DK0405578T3 (da) Enzymimmunoassay for antigen samt fast fase anvendt detil
FI954029A (fi) Kemiluminesoiva reagenssi ja analyysimenetelmä, jossa käytetään substituoitua asetanilidia valon muodostukseen
ATE223047T1 (de) Immunchemische bestimmung von multivalenten analyten
IL143057A (en) Method to determine if a compound causes a change in the structure of apolipoprotein b-100 in a cholesterol- containing low-density lipoprotein and increases binding of an epitope on the apolipoprotein b - 100 to the ldl - receptor
ATE48037T1 (de) Verfahren und reagenz zur verwendung zur bestimmung von pivka-ii.
DK0974842T3 (da) Reagensmiddel til undersøgelse af virus-agglutination og sæt til virusundersøgelse
DK26587A (da) Monoklonalt antistof, maalemetode for glucosyleret protein ved anvendelse af det monoklonale antistofog kit omfattende dette
DE3583002D1 (de) Glucosaminderivate und reagenz zur bestimmung von n-acetyl-beta-d-glucosaminidase welche dieses derivat als substrat enthaelt.
DE69021036D1 (de) Test-Anordnungssystem für integrierte Schaltungen unter Verwendung von lateralen Transistoren.
DK1021719T3 (da) Fremgangsmåde til påvisning af antistoffer i en pröve
DK0738735T3 (da) Aminoterminalt propeptid af type I procollagen, antistoffer dertil og analysemetode ved anvendelse deraf
DK0492499T3 (da) Fremgangsmåde til bestemmelse af en analyt
FI872039A (fi) Flussmedel foer anvaendning vid staolframstaellning.
AU4908799A (en) Determination of the hydrophobic pulmonary surfactant protein sp-c
DE68906742D1 (de) Testsatz zum nachweis von denaturierten lipoproteinen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition